000627 Hubei Biocause Pharmaceutical
- 2.58
- -0.29-10.10%
Hubei Biocause Pharmaceutical News
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement of Tianmao Industrial Group Co., Ltd. on the progress of the repurchase of the company\'s shares
Tianmao Group: Semi-Annual Report Board Resolution Announcement
Tianmao Group: Announcement on the appointment of the company\'s senior management and other personnel
Tianmao Group: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Tianmao Group: Announcement of the resolution of the board of supervisors on the semi-annual report
Tianmao Group: 2024 Semi-Annual Financial Report
Tianmao Group: Guohua Life 2024 Semi-Annual Report
Tianmao Group: Semi-Annual Financial Report
Tianmao Group: 2024 Semi-Annual Report
Tianmao Group: 2024 Semi-Annual Report Summary
Tianmao Group: Legal Opinion of Tianmao Group\'s 2024 Third Extraordinary General Meeting of Shareholders
Tianmao Group: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Tianmao Group: Announcement on the completion of the general election of the Board of Directors and the Board of Supervisors
Hubei Biocause Pharmaceutical: Statement and Commitment of the Independent Director Candidate (Zhang Xiaomiao) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Statement and Commitment of Independent Director Candidate (Jiang Haihua) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Tianmao Industrial Group Co., Ltd. voluntary information disclosure announcement regarding the premium income of China Best Life Insurance Co., Ltd.
Hubei Biocause Pharmaceutical: Announcement Regarding Revision of the Articles of Association, Shareholders' Meeting Rules, Board of Directors Meeting Rules, and Board of Supervisors Meeting Rules.
Analysis
Price Target
No Data
